N/A N=66 "Laparoscopic" Cystoscopy Versus Traditional Cystoscopy
Lower Urinary Tract Injury
Primary: Time Required to Perform Procedure (in Seconds) — 137; 451 seconds
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=36 Rigid Versus Flexible Cystoscopy in Women
Hematuria · Urination Disorders · Voiding Dysfunction
Primary: Visual Analog Scale for Pain — 1.8; 1.4 Units on a Scale — p=.39
N/A N=73 Real-world Evidence Study on Cystistat
Interstitial Cystitis and Bladder Pain Syndrome
Primary: Patient Global Assessment (PGA) — 90.1 percentage of participants (%)
N/A N=176 Evaluation of Ureteral Jets on Cystoscopy
Injury of Ureter
Primary: Ureteral Jet Visibility — 22; 35; 27; 41 Participants
Phase 3 N=304 A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Bladder Cancer
Primary: Proportion of Patients With Histologically Confirmed Malignancy Where Malignancy is Only Detected With Blue Light Cystoscopy With Cysview and Not White Light Cystoscopy…
N/A N=60 Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy
Bacteriuria
Primary: Number of Participants Who Had Post-Procedure Bacteriuria — 0; 1 Participants
N/A N=122 Trendelenburg, Abdominal Insufflation and Time to Completion of Cystoscopy
Bladder Integrity · Bladder Function · Ureteral Integrity
Primary: Time in Seconds to Complete the Cystourethroscopy — 103; 117; 147; 82 seconds
N/A N=100 Trial Comparing Outpatient Flexible to Rigid Cystoscopy in Females
Pain
Primary: Post Procedural Complications, Including Frequency, Urgency, Infection and Time to Resolution of These Symptoms Between the Two Procedures. — 17; 15; 5; 15 participants
N/A N=180 Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope
Kidney Calculi · Ureter Calculi
Primary: Overall Procedure Time — 64.5; 54.1 minutes
N/A N=130 Ureteroscope Caliber and Surgeon Stress
Ureteral Stones · Ureteroscopic Lithotripsy
Primary: Change in STAI-TX1 Score (Postoperative - Preoperative) — 1.35; 5.05 Scores on a scale
N/A N=120 Colonoscope Passive Bending Function
Colitis · Adenoma · Carcinoma
Primary: Patient Assessment of Pain Experienced During Colonoscopy — 19; 10 participants
Phase 4 N=242 Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
Urinary Tract Infections
Primary: Urinary Tract Infection — 11; 12 UTI
N/A N=95 Impact Ureteral Sheath Design During Ureteroscopy
Renal Stone · Nephrolithiasis · Urolithiasis
Primary: Number of Participants With Successful Sheath Placement — 37; 39 Participants
N/A N=551 Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
Bladder Cancer
Primary: Recurrence Free Survival — 9.6; 16.4 months — p=0.056
N/A N=75 The Clinical Utility of Cholangioscopy and Pancreatoscopy in the Diagnosis and Management of Pancreaticobiliary Disorders
Disorders of the Pancreas and Biliary Tree
Primary: Successful Procedure Completion — 70; 5 participants
N/A N=37 Evaluation of Sodium Fluorescein Use During Intraoperative Cystoscopy After Total Laparoscopic Hysterectomy
Ureteral Injury
Primary: Quality of Ureteral Efflux Coloration With Sodium Fluorescein Collected With Dedicated Questionnaire — 23; 4; 1; 1 Participants
Phase 3 N=37 Bladder Scan of Residual Urine With New Catheter
Urinary Incontinence
Primary: Mean Residual Urine Volume — 12.4; 9.4 mL
Phase 3 N=158 Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer
Bladder Cancer
Primary: Number of Patients With Histology-confirmed Lesions (Ta, T1, or CIS) Who Have at Least One Such Lesion Found by Hexvix Blue Light Cystoscopy But Not by White Light…
N/A N=57 Colonoscope Insertion Trial Protocol
Colorectal Cancer
Primary: Time to Intubate the Cecum — 271; 403 seconds
Phase 4 N=130 Evaluation of Ureteral Patency in the Post-indigo Carmine Era
Ureteral Patency
Primary: Visual Analog Scale (VAS) — 48; 20; 0; 28 score on a scale
Phase 4 N=53 Intranasal Fentanyl as an Analgesic for Cystoscopic Procedures
Pain
Primary: Pre Procedure 0 - 10 Pain Numerical Rating Scale — 0; 0; 7; 5 0 - 10 Pain Numerical Rating Scale
Phase 3 N=233 A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer
Bladder Cancer
Primary: Proportion of Patients With Histologically Confirmed Recurrence Within One 1 Year. — 30.5; 47.3 precentage of participants — p=0.05
N/A N=88 Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS
Biliary Tract Disease
Primary: Number of Participants With Procedure Technical Success — 70; 3 participants
N/A N=171 A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology
Nephrolithiasis
Primary: Operative Time — 36; 37 minutes
N/A N=60 To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease
Urinary Tract Disease
Primary: Procedure Success Rate of LithoVue Ureteroscope System at 4Weeks4Weeks ± 7 Days From Procedure — 100 percentage of participants
N/A N=612 Endocuff Vision Colonoscopy vs. AmplifEYE Colonoscopy
Colorectal Adenoma · Colorectal Polyp · Colorectal Cancer
Primary: Number of Adenomas Detected Per Colonoscopy (APC). — 1.63; 1.51 adenomas
N/A N=2 Self-Catheterization Mirror System for Female Patients
Spinal Cord Injury
Primary: System Usability Scale — 4; 7 score on a Likert scale
N/A N=244 Randomized Controlled Trial Comparing Adult to Pediatric Colonoscope in Obese Patients.
Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2) · Screening Colonoscopy
Primary: Composite of Reaching the Cecum in Less Than 10 Minutes Without Changing the Scope Type. — 113; 116 Participants
Phase 3 N=779 Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
Bladder Cancer
Primary: Proportion of Patients With >= 1 Ta or T1 Tumor Detected With Blue Light and Not White Light — 16.4 percentage of participants
N/A N=14 Study to Evaluate the Safety and Initial Effectiveness of the Sinusway™ for Endoscopy of Sinuses in Conjunction With BSD
Sinusitis
Primary: Number of Adverse Device Effects — 0 events